Literature DB >> 18946759

Chemotherapy consisting of paclitaxel and carboplatin benefits a patient with malignant mixed müllerian tumor of the fallopian tube.

Wakae Kawaguchi1, Hiroaki Itamochi, Junzo Kigawa, Yasunobu Kanamori, Tetsuro Oishi, Muneaki Shimada, Shinya Sato, Seiya Sato, Naoki Terakawa.   

Abstract

Malignant mixed müllerian tumors (MMMT) of the fallopian tube are extremely rare, and optimal therapy for them is unknown. A 71-year-old woman presented to us with symptoms of abdominal distension and nausea. A right salpingo-oophorectomy was performed. Pathological examination determined International Federation of Gynecology and Obstetrics (FIGO) stage IIIc MMMT of the right fallopian tube. Of note, multiple tumoral nodules were attached to the sigmoid colon. The patient received three courses of chemotherapy, consisting of 175 mg/m(2) paclitaxel and AUC=5 carboplatin (TC therapy), administered at 3-week intervals. A second, debulking, surgery was then performed, consisting of total abdominal hysterectomy, left salpingo-oophorectomy, and pelvic and paraaortic lymphadenectomy. The tumor attached to the sigmoid colon had shrunk by 60% after chemotherapy. The patient received an additional five courses of adjuvant TC therapy. The patient is alive and free of disease 28 months after the debulking surgery. TC therapy may be effective for MMMT of the fallopian tube.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18946759     DOI: 10.1007/s10147-008-0767-1

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  11 in total

1.  Malignant mixed müllerian tumors of the ovary: histopathologic and clinical review of 36 cases.

Authors:  A-C. Hellström; G. Tegerstedt; C. Silfverswärd; F. Pettersson
Journal:  Int J Gynecol Cancer       Date:  1999-07       Impact factor: 3.437

Review 2.  Malignant mixed Mullerian tumor of the fimbriated end of the fallopian tube: origin as an intraepithelial carcinoma.

Authors:  Jean-Pierre Gagner; Khush Mittal
Journal:  Gynecol Oncol       Date:  2005-04       Impact factor: 5.482

3.  Malignant mixed müllerian tumor of the fallopian tube.

Authors:  C G Zorlu; O Cobanoglu; E Kuşçu; D Aribas
Journal:  Acta Obstet Gynecol Scand       Date:  1994-04       Impact factor: 3.636

Review 4.  Diagnosis and clinical management in malignant Müllerian tumors of the fallopian tube. A report of four cases and review of recent literature.

Authors:  L C Horn; C Werschnik; K Bilek; C Emmert
Journal:  Arch Gynecol Obstet       Date:  1996       Impact factor: 2.344

5.  Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A Gynecologic Oncology Group pathologic study of 203 cases.

Authors:  S G Silverberg; F J Major; J A Blessing; B Fetter; F B Askin; S Y Liao; A Miller
Journal:  Int J Gynecol Pathol       Date:  1990       Impact factor: 2.762

6.  Malignant mixed müllerian tumors of the ovary: experience with cytoreductive surgery and platinum-based combination chemotherapy.

Authors:  J E Mok; Y M Kim; M H Jung; K R Kim; D Y Kim; J H Kim; Y T Kim; J H Nam
Journal:  Int J Gynecol Cancer       Date:  2006 Jan-Feb       Impact factor: 3.437

7.  A clinical and pathologic study of 30 cases of malignant mixed mullerian epithelial and mesenchymal ovarian tumors: a Gynecologic Oncology Group study.

Authors:  C P Morrow; G d'Ablaing; L W Brady; J A Blessing; M M Hreshchyshyn
Journal:  Gynecol Oncol       Date:  1984-07       Impact factor: 5.482

Review 8.  Malignant mixed Müllerian tumor of the fallopian tube: report of two cases and review of literature.

Authors:  M Imachi; N Tsukamoto; T Shigematsu; T Watanabe; K Uehira; S Amada; T Umezu; H Nakano
Journal:  Gynecol Oncol       Date:  1992-10       Impact factor: 5.482

Review 9.  Malignant mixed müllerian tumor of the fallopian tube.

Authors:  J A Carlson; B L Ackerman; J E Wheeler
Journal:  Cancer       Date:  1993-01-01       Impact factor: 6.860

Review 10.  Malignant mixed müllerian tumor of fallopian tube with multiple distinct heterologous components.

Authors:  B J Lim; J W Kim; W I Yang; N H Cho
Journal:  Int J Gynecol Cancer       Date:  2004 Jul-Aug       Impact factor: 3.437

View more
  5 in total

1.  Malignant mixed Mullerian tumors of the uterus: histopathological evaluation of cell cycle and apoptotic regulatory proteins.

Authors:  Rani Kanthan; Jenna-Lynn B Senger; Dana Diudea
Journal:  World J Surg Oncol       Date:  2010-07-19       Impact factor: 2.754

2.  Primary malignant mixed müllerian tumor of the fimbriated end of the fallopian tube causing hematosalpinx and hematometra.

Authors:  Dagistan Tolga Arioz; Sezgin Yilmaz; Nazan Okur; Fatma Aktepe; Mehmet Yilmazer; Sinan Ozalp
Journal:  N Am J Med Sci       Date:  2012-12

3.  Paclitaxel-ifosfamide-carboplatin combination chemotherapy regimen in advanced uterine and adnexal malignant mixed Mullerian tumours.

Authors:  C Kosmas; G Vorgias; G Tsakonas; P Politis; T Daladimos; E Panagiotidi; T Papachrysanthou; D Moschovis; N Kalinoglou; N Tsavaris; A Karabelis; N Mylonakis
Journal:  Br J Cancer       Date:  2011-08-16       Impact factor: 7.640

4.  Primary malignant mixed Müllerian tumors of the fallopian tube with cervix metastasis: A rare case report and literature review.

Authors:  QinHe Zhang; Ailian Liu; Jing Jun Wu; Miao Niu; Ying Zhao; Shi Feng Tian; AnLiang Chen; Lin Zhong
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

5.  Malignant mixed Müllerian tumor of the fallopian tube: Case report and literature review.

Authors:  Alexandra Lavinia Cozlea; Mihai Gheorghe; Szilard Leo Kiss; Anas Fandi; Mihai Stanca; Simona Mocan; Mihai Emil Căpîlna; Nicolae Bacalbașa; Andreea Anamaria Moldovan
Journal:  Exp Ther Med       Date:  2021-12-28       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.